Literature DB >> 23365084

NFATc1 induction in peripheral T and B lymphocytes.

Matthias Hock1, Martin Vaeth, Ronald Rudolf, Amiya Kumar Patra, Duong Anh Thuy Pham, Khalid Muhammad, Tobias Pusch, Tobias Bopp, Edgar Schmitt, Rene Rost, Friederike Berberich-Siebelt, Dimitri Tyrsin, Sergei Chuvpilo, Andris Avots, Edgar Serfling, Stefan Klein-Hessling.   

Abstract

NFAT transcription factors control the proliferation and survival of peripheral lymphocytes. We have reported previously that the short isoform NFATc1/αA whose generation is induced by immune receptor stimulation supports the proliferation and inhibits the activation-induced cell death of peripheral T and B cells. We will show in this study that in novel bacterial artificial chromosome transgenic mice that express EGFP under the control of entire Nfatc1 locus the Nfatc1/Egfp transgene is expressed as early as in double-negative thymocytes and in nonstimulated peripheral T and B cells. Upon immune receptor stimulation, Nfatc1/Egfp expression is elevated in B, Th1, and Th2 cells, but only weakly in T regulatory, Th9, and Th17 cells in vitro whose generation is affected by TGFβ. In naive lymphocytes, persistent immune receptor signals led to a 3-5 increase in NFATc1/αA RNA levels during primary and secondary stimulation, but a much stronger induction was observed at the protein level. Whereas anti-CD3(+)CD28 stimulation of primary T cells induces both NFATc1/αA and their proliferation and survival, anti-IgM stimulation of B cells induces NFATc1/αA and proliferation, but activation-induced cell death after 3-d incubation in vitro. The anti-IgM-mediated activation-induced cell death induction of B cells in vitro is suppressed by anti-CD40-, LPS-, and CpG-mediated signals. In addition to inducing NF-κB factors, together with anti-IgM, these signals also support the generation of NFATc1/αA. According to these data and the architecture of its promoter region, the Nfatc1 gene resembles a primary response gene whose induction is affected at the posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365084     DOI: 10.4049/jimmunol.1201591

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.

Authors:  Pedro I Lucena; Douglas V Faget; Emilia Pachulec; Marcela C Robaina; Claudete E Klumb; Bruno K Robbs; João P B Viola
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

2.  Hematopoietic Stem and Progenitor Cell Maintenance and Multiple Lineage Differentiation Is an Integral Function of NFATc1.

Authors:  Carlotta Barahona de Brito; Stefan Klein-Hessling; Edgar Serfling; Amiya Kumar Patra
Journal:  Cells       Date:  2022-06-23       Impact factor: 7.666

3.  Store-Operated Ca(2+) Entry in Follicular T Cells Controls Humoral Immune Responses and Autoimmunity.

Authors:  Martin Vaeth; Miriam Eckstein; Patrick J Shaw; Lina Kozhaya; Jun Yang; Friederike Berberich-Siebelt; Robert Clancy; Derya Unutmaz; Stefan Feske
Journal:  Immunity       Date:  2016-05-31       Impact factor: 31.745

4.  Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.

Authors:  Sascha Kahlfuß; Narasimhulu Simma; Judith Mankiewicz; Tanima Bose; Theresa Lowinus; Stefan Klein-Hessling; Rolf Sprengel; Burkhart Schraven; Martin Heine; Ursula Bommhardt
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

5.  Analysis of serum miRNA profiles of myasthenia gravis patients.

Authors:  Gisela Nogales-Gadea; Alba Ramos-Fransi; Xavier Suárez-Calvet; Miquel Navas; Ricard Rojas-García; Jose Luis Mosquera; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Isabel Illa
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells.

Authors:  Narasimhulu Simma; Tanima Bose; Sascha Kahlfuss; Judith Mankiewicz; Theresa Lowinus; Fred Lühder; Thomas Schüler; Burkhart Schraven; Martin Heine; Ursula Bommhardt
Journal:  Cell Commun Signal       Date:  2014-12-05       Impact factor: 5.712

Review 7.  Architecture and expression of the nfatc1 gene in lymphocytes.

Authors:  Ronald Rudolf; Rhoda Busch; Amiya K Patra; Khalid Muhammad; Andris Avots; Jean-Christophe Andrau; Stefan Klein-Hessling; Edgar Serfling
Journal:  Front Immunol       Date:  2014-02-03       Impact factor: 7.561

8.  Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression.

Authors:  Martin Vaeth; Gerd Müller; Dennis Stauss; Lena Dietz; Stefan Klein-Hessling; Edgar Serfling; Martin Lipp; Ingolf Berberich; Friederike Berberich-Siebelt
Journal:  J Exp Med       Date:  2014-03-03       Impact factor: 14.307

9.  NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells.

Authors:  Hani Alrefai; Khalid Muhammad; Ronald Rudolf; Duong Anh Thuy Pham; Stefan Klein-Hessling; Amiya K Patra; Andris Avots; Valesca Bukur; Ugur Sahin; Stefan Tenzer; Matthias Goebeler; Andreas Kerstan; Edgar Serfling
Journal:  Nat Commun       Date:  2016-05-25       Impact factor: 14.919

10.  A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development.

Authors:  Stefan Klein-Hessling; Ronald Rudolf; Khalid Muhammad; Klaus-Peter Knobeloch; Muhammad Ahmad Maqbool; Pierre Cauchy; Jean-Christophe Andrau; Andris Avots; Claudio Talora; Volker Ellenrieder; Isabella Screpanti; Edgar Serfling; Amiya Kumar Patra
Journal:  Nat Commun       Date:  2016-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.